Currently, cagrilintide remains investigational and available only as a research chemical pending FDA approval expected 2025-2026
For additional glycemic control, the dosage can be increased to 10 mg orally once daily
Our innovative and personalized approach allows our healthcare professionals to guide you through these choices
These issues can lead to symptoms like: Bloating (especially after meals) Diarrhoea or constipation Excessive gas or frequent burping Nausea or feeling full quickly Abdominal pain or cramping Its estimated in people with IBS, SIBO may contribute to symptoms in around 38% of cases
The related Lilly drug tirzepatide lists hair loss as a common side effect on its approved label, and alopecia has also been reported in trials of the newer oral drug orforglipron, which is consistent with a class effect driven by weight loss rather than by one specific molecule
Just one thing Try this today: Did you know that the foods you eat may cause constipation
